Contract Services Clinical Research

Merck's JAVELIN Bladder Regimen Shines in Real-World Data, Elevating Standard Care for Urothelial Carcinoma

Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...

 January 23, 2024 | News

LOTTE BIOLOGICS and NJ Bio, Inc. Forge Strategic Partnership to Revolutionize ADC Services

This partnership leverages LOTTE BIOLOGICS' extensive proficiency in antibody manufacturing and NJ Bio's specialized skills in ADC process development, as ...

 January 22, 2024 | News

Japan greenlights historic treatment for ultra-rare Progeria, marking a significant breakthrough in addressing rapid-aging diseases.

The Progeria Research Foundation (PRF) today announced a new milestone with the approval of Zokinvy™ (lonafarnib) by the Japanese Ministry of Health,...

 January 22, 2024 | News

Complete Genomics and Gencove Partner for Bundled Low-Pass Whole Genome Sequencing Solution at PAG 31

The partnership will combine Gencove's platform for data analytics and management with Complete Genomics' sequencing products and automation capabilit...

 January 17, 2024 | News

SOPHiA GENETICS and Karkinos Healthcare Partner to Advance Cancer Research in India

SOPHiA GENETICS technology helps advance cancer research across India SOPHiA GENETICS and Karkinos Healthcare join forces to propel cutting-edge geno...

 January 15, 2024 | News

ClinChoice Strengthens Global Presence with Acquisition of CSI, Ventures into Southeast Asia

Through this strategic acquisition, ClinChoice further broadens its global footprint and full-service capabilities in more than 30 countries throughout&nbs...

 January 12, 2024 | News

VerImmune and A*STAR Join Forces in Research Collaboration to Propel ViP Platform Development

The collaboration is centered around platform development and aims to develop a preclinical manufacturing platform, which will facilitate the generation of...

 January 11, 2024 | News

Beckman Coulter Launches Groundbreaking Anti-TRBC2 Conjugated Antibody for Flow Cytometry

Traditional approaches to identify clonal T-cell expansion have been complex and challenging, relying on the assessment of abnormal antigen expression, whi...

 January 09, 2024 | News

Evotec Advances Strategic Neuroscience Partnership with Bristol Myers Squibb

Evotec SE announced progress within the Company’s strategic partnership with Bristol Myers Squibb, further bolstering the joint pipeline of advanced ...

 January 08, 2024 | News

Shanghai Argo Partners with Novartis in Multi-Program RNAi Licensing and Collaboration

- Argo will receive upfront payments of $185 million from Novartis and is eligible to receive potential option and milestone payments as wel...

 January 08, 2024 | News

Clarametyx Biosciences Secures $33M in Series A Funding for Anti-Biofilm Biologics Development

Clarametyx Biosciences Inc. (“Clarametyx”), a clinical stage company developing targeted, immune-enabling biologic therapies to counter persist...

 January 08, 2024 | News

Kexing Biopharm Expands Global Portfolio with Eribulin Mesylate Injection

Eribulin Mesylate Injection is indicated for patients with locally advanced or metastatic breast cancer who have undergone at least two chemotherapy r...

 January 08, 2024 | News

Thermo Fisher Introduces PangenomiX Array for Large-Scale Disease and Pharmacogenomics Research

Earlier this year, scientists unveiled the first draft of the pangenome, based on full genetic blueprints from 47 people around the world to create a more ...

 January 05, 2024 | News

Australia's GPN Vaccines Reports Positive Phase 1 Data for Gamma-PN Trial

In this double-blind, randomised study with placebo and active controls, 120 participants received either two doses of 50, 250 or 1000 micrograms of Gamma-...

 January 04, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close